Cover Image

Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma

Abstract An active host adaptive response is characterized by the existence of programmed cell death protein 1 (PD‐1)+/IFN‐γ+ cytotoxic T cells and IFN‐γ‐induced PD‐L1+ tumor cells (TCs), which predicts high response rate to anti‐PD‐1/L1 therapy. Recently, CD161 and its ligand LLT1 (CLEC2D) have bee...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xinyang Hu (Author), Yuexin Dong (Author), Shixin Xie (Author), Yuxian Song (Author), Chenhang Yu (Author), Yijia He (Author), Zhiyong Wang (Author), Qingang Hu (Author), Yanhong Ni (Author), Liang Ding (Author)
Format:	Book
Published:	Wiley, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Percentages of CD4+CD161+ and CD4−CD8−CD161+ T Cells in the Synovial Fluid Are Correlated with Disease Activity in Rheumatoid Arthritis
by: Jinlin Miao, et al.
Published: (2015)

Achievement of LDL-Cholesterol Goals in Patients Receiving LLT in Primary Care: TERESA-AP Study
by: Sergio Cinza-Sanjurjo, et al.
Published: (2024)

A simple and automated method for 161Tb purification and ICP-MS analysis of 161Tb
by: Scott W. McNeil, et al.
Published: (2022)

Whole issue 16.1
by: Language Value
Published: (2023)

Implementing the language comprehension test C-BiLLT: a qualitative description study using the COM-B model of behaviour change
by: J. N. Bootsma, et al.
Published: (2022)

Expression of senescence-related CD161 promotes extranodal NK/T cell lymphoma by affecting T cell phenotype and cell cycle
by: Chengxun Jin, et al.
Published: (2024)

CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells
by: Michael L Freeman, et al.
Published: (2017)

Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma
by: Emer Lynch, et al.
Published: (2023)

Overview of immunology of oral squamous cell carcinoma
by: Anisha Cynthia Sathiyasekar, et al.
Published: (2016)

The Strand Magazine, Vol. 27, No. 161, May 1904
by: Various

Clinicopathological profile and management of 161 cases of actinic cheilitis
by: Maria Luiza Diniz de Sousa Lopes, et al.
Published: (2015)

Analiza,komórek,CD4+CD161+CD196+,i,CD4+IL-17+,Th17,we,krwi,obwodowej,u,młodocianych,z,zapaleniem,tarczycy,typu,Hashimoto,i,chorobą,Gravesa-Basedowa
by: Hanna Borysewicz-Sańczyk, et al.
Published: (2012)

IMPLEMENTATION OF STUDENT DISCIPLINE CHARACTER VALUE AT SDN 161 PEKANBARU
by: Citra Novita Laura, et al.
Published: (2023)

Regional odontodysplasia: An analysis of 161 cases from 1953 to 2017
by: Ohoud Alotaibi, et al.
Published: (2019)

Regional odontodysplasia: An analysis of 161 cases from 1953 to 2017
by: Ohoud Alotaibi, et al.
Published: (2019)

Immunologic checkpoints in cancer therapy: focus on the programmed death-1 (PD-1) receptor pathway
by: Momtaz P, et al.
Published: (2014)

At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma
by: Niels E. Wondergem, et al.
Published: (2021)

Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations
by: Paolo Bossi, et al.
Published: (2021)

The Expression and Therapeutic Potential of Checkpoint Kinase 2 in Laryngeal Squamous Cell Carcinoma
by: Tian Y, et al.
Published: (2020)

Checkpoint inhibitor blockade and epigenetic reprogrammability in CD8 T-cell activation and exhaustion
by: José Belizário, et al.
Published: (2020)

STUDY OF THE IMMUNOLOGICAL MARKERS CD49d AND CD38 IN EARLY-STAGE B-CLL PATIENTS
by: Vanya Popova, et al.
Published: (2018)

The emerging landscape of immune checkpoint inhibitor based clinical trials in adults with advanced rare tumors
by: Arjun Mittra, et al.
Published: (2021)

Sławomir Chrost, Podstawy pedagogii osoby, Wydawnictwo Difin, Warszawa 2022, ss. 161
by: Michał Stachurski
Published: (2022)

The influence of gender and smoking on hidradenitis suppurativa: A retrospective study of 161 patients in Taiwan
by: Chia-Bao Chu, et al.
Published: (2021)

Epstein-Barr virus predominance and immunological abnormalities in oral squamous cell carcinoma
by: Ahmed Talib Ghadhban, et al.
Published: (2023)

NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma
by: Yu X, et al.
Published: (2023)

The landscape overview of CD47-based immunotherapy for hematological malignancies
by: Hua Yang, et al.
Published: (2023)

First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress
by: Zhangfeng Huang, et al.
Published: (2020)

The fatty acids and atherosclerotic vascular disease - doi:10.5020/18061230.2004.p161
by: Carlos Antonio Bruno da Silva, et al.
Published: (2012)

Immunological Perspective: Helicobacter pylori Infection and Gastritis
by: Hang Yang, et al.
Published: (2022)

The landscape of alternative splicing in HIV-1 infected CD4 T-cells
by: Seyoun Byun, et al.
Published: (2020)

Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma
by: Chao Zhu, et al.
Published: (2021)

Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report
by: Cheng Fang, et al.
Published: (2019)

OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
by: G.E. Martin, et al.
Published: (2017)

Clinical and genetic analysis of two phenotypically normal families carrying 4p16.1 microduplications
by: Xiaolin Wang, et al.
Published: (2024)

Production and characterization of no-carrier-added 161Tb as an alternative to the clinically-applied 177Lu for radionuclide therapy
by: Nadezda Gracheva, et al.
Published: (2019)

Temporal trends in dietary creatine intake from 1999 to 2018: an ecological study with 89,161 participants
by: Darinka Korovljev, et al.
Published: (2021)

Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
by: Wu J, et al.
Published: (2022)

CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma
by: Pouyan Amini Shakib, et al.
Published: (2015)

CD4+ T-cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIV
by: L.M. Gangcuangco, et al.
Published: (2019)